| 000 | 01800 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517184411.0 | ||
| 264 | 0 | _c20190107 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1532-2149 | ||
| 024 | 7 |
_a10.1002/ejp.1146 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDrinovac Vlah, V | |
| 245 | 0 | 0 |
_aRole of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region. _h[electronic resource] |
| 260 |
_bEuropean journal of pain (London, England) _c03 2018 |
||
| 300 |
_a583-591 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xpharmacology |
| 650 | 0 | 4 |
_aDura Mater _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aMorphine _xpharmacology |
| 650 | 0 | 4 |
_aNaltrexone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
| 650 | 0 | 4 | _aNeurogenic Inflammation |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aNociception _xdrug effects |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aQuaternary Ammonium Compounds _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSciatic Nerve |
| 650 | 0 | 4 |
_aTrigeminal Caudal Nucleus _xdrug effects |
| 650 | 0 | 4 | _aTrigeminal Nerve |
| 700 | 1 | _aFilipović, B | |
| 700 | 1 | _aBach-Rojecky, L | |
| 700 | 1 | _aLacković, Z | |
| 773 | 0 |
_tEuropean journal of pain (London, England) _gvol. 22 _gno. 3 _gp. 583-591 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ejp.1146 _zAvailable from publisher's website |
| 999 |
_c27785220 _d27785220 |
||